Is there a need to repeat single assay reactive HIV screens? A review of practice in two UK sites
Callum Goolden, Williams Cheryl, Sabeen Khurshid Zaidi, Joel Paul et autres
1 citationJournal of Clinical Virology
Shazaad Ahmad
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
9Publications signalées
134Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsSARS-CoV-2 detection and testingCOVID-19 Clinical Research StudiesHIV/AIDS Research and Interventions
Publications récentes
The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis
Stephen Woolley, I Duru, Luca Pagano, Rebecca Lester et autres
0 citationsJournal of Antimicrobial Chemotherapy
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
Seb Cotton, M. McHugh, Rebecca Dewar, J.G. Haas et autres
2 citationsJournal of Hospital Infection
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra Rzeszutek et autres
42 citationsNature Communications
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders, Calley Middleton et autres
81 citationsThe Lancet Infectious Diseases
Understanding Waiting Lists Pressures
Kevin Fong, Yasser Mushtaq, Thomas House, Dan Gordon et autres
2 citationsmedRxiv
Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathway
Luke Carter‐Brzezinski, Elizabeth Davies, Jane E. Norman, L. J. García Rubio et autres
1 citationLeukemia & lymphoma/Leukemia and lymphoma
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders, Calley Middleton et autres
3 citationsmedRxiv
Characterisation of SARS-CoV-2 genomic variations in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra Rzeszutek et autres
2 citationsResearch Square
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.